Cresco Labs to Acquire Tryke Including the Reef Dispensary Portfolio

Tryke generated US$70.4 million in Revenue and US$24.6 million in EBITDA in fiscal 20181, making it one of the highest grossing and most profitable private cannabis companies in the U.S. market.

Nevada is one of the largest and fastest growing cannabis markets in the U.S. with 2019 sales estimates of up to US$940 million2; Arizona is one of the largest and fastest growing medical-only markets with estimated 2019 sales of up to US$760 million. Continue reading “Cresco Labs to Acquire Tryke Including the Reef Dispensary Portfolio”

CBD Consumers Using Medications Less Often, Cutting Back On Alcohol

Booming interest in products containing cannabidiol (CBD), a therapeutic chemical compound found in cannabis, has resulted in over half of CBD users consuming less prescription and over-the-counter (OTC) medications and supplements, along with over 20% of CBD users consuming alcoholic beverages less frequently, according to a new study by cannabis consumer insights consultants High Yield Insights (HYI). Continue reading “CBD Consumers Using Medications Less Often, Cutting Back On Alcohol”

Cresco Labs Opens Third Pittsburgh Area Dispensary

Cresco Labs (CSE:CL) (OTC:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, today announced the opening of a CY+ dispensary in New Kensington, Pennsylvania. To commemorate the opening, Cresco welcomed Pennsylvania Lieutenant Governor John Fetterman to cut the ceremonial ribbon and to speak about the opioid crisis plaguing the state and Cresco’s role in advancing medicinal cannabis as a safe and accessible alternative for patients. With New Kensington as the third CY+ dispensary to open in Pennsylvania, Cresco has licenses for three more dispensaries planned to open during the second quarter of 2019. Continue reading “Cresco Labs Opens Third Pittsburgh Area Dispensary”

Cresco Labs’ Dispensary Launches Newly Enacted Illinois Opioid Alternative Pilot Program

Cresco Labs (CSE: CL) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced that the Company’s FloraMedex dispensary launched Illinois’ Opioid Alternative Pilot Program (OAPP) today vastly expanding the population of Illinois patients who can access medical cannabis in place of pharmaceutical opioid medications. Under this new program, patients with doctor approval can receive near-immediate access to cannabis products from an Illinois licensed dispensary. Continue reading “Cresco Labs’ Dispensary Launches Newly Enacted Illinois Opioid Alternative Pilot Program”

MedMen Completes Previously Announced Acquisition of Illinois Dispensary

MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF) (FSE: A2JM6N) is pleased to announce that it has closed its previously announced acquisition (the “Acquisition”) of Seven Point, a licensed medical cannabis dispensary located in the historic Chicago suburb of Oak Park, Illinois.

Pursuant to the Acquisition, the Company paid a combination of cash at closing, deferred cash and subordinate voting shares of MedMen, for an undisclosed total amount. Continue reading “MedMen Completes Previously Announced Acquisition of Illinois Dispensary”

Cresco Labs Appoints New Chief Experience Officer

Cresco Labs, one of the largest vertically integrated multi-state cannabis operators in the United States, today announced the appointment of Scott Wilson to the new role of Chief Experience Officer.  As CXO, Wilson will extend Cresco Labs’ mission to professionalize and mainstream cannabis as a conventional consumer product with brands tailored to the largest consumer segments.  Continue reading “Cresco Labs Appoints New Chief Experience Officer”

Cannabis Strategies Acquisition Corp. Announces Proposed Qualifying Transaction

CSAC has executed agreements to acquire 5 existing companies to create an anchor portfolio (the “Anchor Portfolio”) of vertically integrated operations in the Eastern and Western United States, pending regulatory approval on licensing and structure… Continue reading “Cannabis Strategies Acquisition Corp. Announces Proposed Qualifying Transaction”

High Park Farms™ Receives Cannabis Sales License from Health Canada

High Park Farms™ Ltd., a subsidiary of Tilray, Inc. (NASDAQ: TLRY), announced today that it has received its sales license from Health Canada to sell cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The license will allow High Park Farms to supply and sell finished cannabis products within the ACMPR as well as sales in anticipation of the launch of the adult-use market in Canada upon its legalization on October 17, 2018. Continue reading “High Park Farms™ Receives Cannabis Sales License from Health Canada”

TGOD Announces C$75 Million Bought Deal

The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) (US:TGODF) is pleased to announce that it has entered into an agreement with a syndicate of underwriters led by Canaccord Genuity Corp. (the “Underwriters”) pursuant to which the Underwriters have agreed to purchase, on a bought deal basis pursuant to the filing of a short form prospectus, an aggregate of 10,950,000 units (the “Units”) at a price of $6.85 per Unit (the “Offering Price”) for aggregate gross proceeds to the Company of $75,007,500 (the “Offering”). Continue reading “TGOD Announces C$75 Million Bought Deal”

Cova Software Announces Plan to Retain Retail Cannabis Data in Canada

Retail cannabis point of sale software company and part of the iQmetrix group, Cova Software today announced plans to help retailers in Canada improve protection of retail data and Canadian consumer information by migrating all Canadian cannabis retail data to Azure Canada-Central located in Toronto. The move is set to begin September 27. Continue reading “Cova Software Announces Plan to Retain Retail Cannabis Data in Canada”